Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
33.98
-1.12 (-3.19%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Capricor Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
1,9651,4936271519771
Upgrade
Market Cap Growth
384.57%137.87%316.72%54.55%37.70%0.89%
Upgrade
Enterprise Value
1,6621,4095441245430
Upgrade
Last Close Price
33.9828.8613.804.893.862.93
Upgrade
PS Ratio
--28.185.9838.19288.92
Upgrade
PB Ratio
6.384.884.316.668.272.26
Upgrade
P/TBV Ratio
6.434.884.316.668.272.26
Upgrade
P/FCF Ratio
----62.58-
Upgrade
P/OCF Ratio
----19.82-
Upgrade
EV/Sales Ratio
--24.434.9421.01122.30
Upgrade
EV/FCF Ratio
----34.43-
Upgrade
Debt / Equity Ratio
0.050.050.010.100.220.09
Upgrade
Debt / FCF Ratio
----1.64-
Upgrade
Net Debt / Equity Ratio
-0.99-0.99-1.03-1.65-3.30-1.02
Upgrade
Net Debt / EBITDA Ratio
2.862.863.651.621.331.55
Upgrade
Net Debt / FCF Ratio
3.723.723.611.35-24.961.78
Upgrade
Asset Turnover
--0.190.460.060.01
Upgrade
Quick Ratio
8.888.887.701.591.788.54
Upgrade
Current Ratio
9.019.017.771.631.828.82
Upgrade
Return on Equity (ROE)
-46.56%-46.56%-48.16%-129.63%-134.49%-67.23%
Upgrade
Return on Assets (ROA)
-25.68%-25.68%-23.21%-27.66%-40.60%-34.46%
Upgrade
Return on Capital Employed (ROCE)
-33.80%-33.80%-28.50%-87.70%-112.00%-56.30%
Upgrade
Earnings Yield
-5.34%-7.04%-6.45%-14.80%-29.78%-28.30%
Upgrade
FCF Yield
-4.15%-5.46%-6.62%-18.36%1.60%-25.45%
Upgrade
Buyback Yield / Dilution
-31.97%-31.97%-31.52%-9.06%-6.34%-48.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.